Toward a multi-level strategy to reduce stigma in global mental health: overview protocol of the Indigo Partnership to develop and test interventions in low- and middle-income countries

International Journal of Mental Health Systems

Comment

Sara Evans-Lacko¹  Maya Semrau²  Graham Thornicroft³  Petra C. Gronholm³  Tatiana Taylor Salisbury⁴  Charlotte Hanlon⁵  Ioannis Bakolis⁶  Claire Henderson⁷  Heidi Lempp⁸  Uta Ouali⁹  Syed Shabab Wahid^1,10  Fahmy Hanna^1,11  Eshetu Girma^1,12  Brandon A. Kohrt^1,13  Pallab K. Maulik^1,14  Kelly Davies^1,15  Renee Romeo^1,16  Santosh Loganathan^1,17  Anish V. Cherian^1,17  Nicole Votruba^1,18  Ning Ma^1,19  Wufang Zhang^1,19  Nicolas Rüsch^2,20  Jie Li^2,21  Dristy Gurung^2,22 

[1] Care Policy and Evaluation Centre, London School of Economics and Political Science, Houghton Street, London, UK;Centre for Global Health Research, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton, UK;Centre for Global Mental Health and Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;Centre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;Centre for Global Mental Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;Department of Psychiatry, WHO Collaborating Centre for Mental Health Research and Capacity-Building, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia;Centre for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia;Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;South London and Maudsley NHS Foundation Trust, London, UK;Centre for Rheumatic Diseases, Department of Inflammation Biology, School of Immunology and Microbial Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK;Department Psychiatry A, Razi University Hospital, La Manouba, Tunisia;Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia;Department of Global Health, School of Health, Georgetown University, Washington, DC, USA;Division of Global Mental Health, Department of Psychiatry and Behavioral Sciences, George Washington University, Washington, DC, USA;Department of Mental Health and Substance Use, World Health Organization, Geneva, Switzerland;Department of Preventive Medicine, School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia;Division of Global Mental Health, Department of Psychiatry and Behavioral Sciences, George Washington University, Washington, DC, USA;George Institute for Global Health, New Delhi, India;Faculty of Medicine, University of New South Wales, Sydney, Australia;Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;King’s Health Economics, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India;Nuffield Department of Women’s & Reproductive Health, University of Oxford, Oxford, UK;The George Institute for Global Health, Imperial College London, London, UK;Peking University Sixth Hospital, Peking University Institute of Mental Health, Beijing, China;Section of Public Mental Health, Department of Psychiatry II, Ulm University and BKH Günzburg, Ulm, Germany;The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China;Transcultural Psychosocial Organization (TPO) Nepal, Kathmandu, Nepal;Centre for Global Mental Health and Centre for Implementation Science, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK;

关键词: Low- and middle-income countries;    Mental health;    Health service research;    Global health;    Community mental health;    Stigma;    Discrimination;    Intervention;   

DOI  :  10.1186/s13033-022-00564-5

 received in 2022-05-25, accepted in 2022-10-31,  发布年份 2022

来源: Springer

【 摘 要 】

There is increasing attention to the impacts of stigma and discrimination related to mental health on quality of life and access to and quality of healthcare. Effective strategies for stigma reduction exist, but most evidence comes from high-income settings. Recent reviews of stigma research have identified gaps in the field, including limited cultural and contextual adaptation of interventions, a lack of contextual psychometric information on evaluation tools, and, most notably, a lack of multi-level strategies for stigma reduction. The Indigo Partnership research programme will address these knowledge gaps through a multi-country, multi-site collaboration for anti-stigma interventions in low- and middle-income countries (LMICs) (China, Ethiopia, India, Nepal, and Tunisia). The Indigo Partnership aims to: (1) carry out research to strengthen the understanding of mechanisms of stigma processes and reduce stigma and discrimination against people with mental health conditions in LMICs; and (2) establish a strong collaborative research consortium through the conduct of this programme. Specifically, the Indigo Partnership involves developing and pilot testing anti-stigma interventions at the community, primary care, and mental health specialist care levels, with a systematic approach to cultural and contextual adaptation across the sites. This work also involves transcultural translation and adaptation of stigma and discrimination measurement tools. The Indigo Partnership operates with the key principle of partnering with people with lived experience of mental health conditions for the development and implementation of the pilot interventions, as well as capacity building and cross-site learning to actively develop a more globally representative and equitable mental health research community. This work is envisioned to have a long-lasting impact, both in terms of the capacity building provided to participating institutions and researchers, and the foundation it provides for future research to extend the evidence base of what works to reduce and ultimately end stigma and discrimination in mental health.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 2